Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Reconstruction of bisphenol A intake using a simple pharmacokinetic model

Abstract

Bisphenol A (BPA) is used in the manufacture of a range of consumer products, and human biomonitoring studies suggest that exposure to BPA is nearly ubiquitous. We constructed and calibrated a simple pharmacokinetic model to predict urinary concentrations of BPA based on a known initial dose. This descriptive (rather than physiologically based) model has three compartments: “stomach/liver,” “blood,” and “bladder.” We calibrated and validated the model parameters using blood and urine measurements from nine volunteers who consumed 5 mg of d16-BPA. We then applied the model to a second group of eight persons, who supplied full volumes of urine over 7 consecutive days and a diary identifying times and types of food and beverage consumed, to “reconstruct” the time and mass of BPA intakes. These reconstructed daily intakes ranged on average from 60 to 100 ng/kg-day, within the range of, but slightly higher than, those surmised from other studies. About two-thirds of intakes occurred within an hour of reported food or drink consumption, supporting the hypothesis that diet is the main pathway of exposure to BPA. However, one-third of all reconstructed intakes took place outside this time window, suggesting that other sources of BPA exposure may also be relevant.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. EPA. Bisphenol A Action Plan. U.S. Environmental Protection Agency, Washington, DC, USA, 2010.

  2. NTP-CERHR. NTP-CERHR Monograph on the Potent ial Human Reproductive and Developmental Effects of Bisphenol A. National Toxicology Program, Center for the Evaluation of Risks to Human Reproduction, 2008 Contract No.: NIH Publication No. 08 – 5994, Research Triangle Park, NC.

  3. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJR, Schoenfelder G . Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 2010; 118: 1055–1070.

    Article  CAS  Google Scholar 

  4. Tsukioka T, Terasawa J, Sato S, Hatayama Y, Makino T, Nakazawa H . Development of analytical method for determining trace amounts of BPA in urine samples and estimation of exposure to BPA. J Environ Chem 2004; 14: 57–63.

    Article  CAS  Google Scholar 

  5. Volkel W, Colnot T, Csanady GA, Filser JG, Dekant W . Metabolism and kinetics of bisphenol A in humans at low doses following oral administration. Chem Res Toxicol 2002; 15: 1281–1287.

    Article  Google Scholar 

  6. Volkel W, Bittner N, Dekant W . Quantitation of bisphenol A and bisphenol A glucuronide in biological samples by high performance liquid chromatography-tandem mass spectrometry. Drug Metab Dispos 2005; 33: 1748–1757.

    Article  Google Scholar 

  7. WHO. Joint FAO/WHO Expert Meeting to Review Toxicological and Health Aspects of Bisphenol A: Summary Report including Report of Stakeholder Meeting on Bisphenol A. World Health Organization: Ottawa, Canada. 2010.

  8. EU. European Union Risk Assessment Report: 4,4′-ISOPROPYLIDENEDIPHENOL (BISPHENOL-A), CAS No: 80-05-7, EINECS No: 201-245-8. European Union: Luxembourg. 2003.

  9. Miyamoto K, Kotake M . Estimation of daily bisphenol a intake of Japanese individuals with emphasis on uncertainty and variability. Environ Sci 2006; 13: 15–29.

    CAS  Google Scholar 

  10. Von Goetz N, Wormuth M, Scheringer M, Hungerbuhler K, Bisphenol A . How the most relevant exposure sources contribute to total consumer exposure. Risk Anal 2010; 30: 473–487.

    Article  Google Scholar 

  11. Wilson NK, Chuang JC, Morgan MK, Lordo RA, Sheldon LS . An observational study of the potential exposures of preschool children to pentachlorophenol, bisphenol-A, and nonylphenol at home and daycare. Environ Res 2007; 103: 9–20.

    Article  CAS  Google Scholar 

  12. Joskow R, Barr DB, Barr JR, Calafat AM, Needham LL, Rubin C . Exposure to bisphenol A from bis-glycidyl dimethacrylate-based dental sealants. J Am Dent Assoc 2006; 137: 353–362.

    Article  CAS  Google Scholar 

  13. Geens T, Goeyens L, Kannan K, Neels H, Covaci A . Levels of bisphenol-A in thermal paper receipts from Belgium and estimation of human exposure. Sci Total Environ 2012; 435-436: 30–33.

    Article  CAS  Google Scholar 

  14. Liao C, Kannan K . Widespread occurrence of bisphenol A in paper and paper products: implications for human exposure. Environ Sci Technol 2011; 45: 9372–9379.

    Article  CAS  Google Scholar 

  15. Rudel RA, Brody JG, Spengler JD, Vallarino J, Geno PW, Sun G et al. Identification of selected hormonally active agents and animal mammary carcinogens in commercial and residential air and dust samples. J Air Waste Manag Assoc 2001; 51: 499–513.

    Article  CAS  Google Scholar 

  16. Rudel RA, Camann DE, Spengler JD, Korn LR, Brody JG . Phthalates, alkylphenols, pesticides, polybrominated diphenyl ethers, and other endocrine-disrupting compounds in indoor air and dust. Environ Sci Technol 2003; 37: 4543–4553.

    Article  CAS  Google Scholar 

  17. Calafat AM, Weuve J, Ye X, Jia LT, Hu H, Ringer S et al. Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Perspect 2009; 117: 639–644.

    Article  CAS  Google Scholar 

  18. Vandentorren S, Zeman F, Morin L, Sarter H, Bidondo ML, Oleko A et al. Bisphenol-A and phthalates contamination of urine samples by catheters in the Elfe pilot study: implications for large-scale biomonitoring studies. Environ Res 2011; 111: 761–764.

    Article  CAS  Google Scholar 

  19. Duty SM, Mendonca K, Hauser R, Calafat AM, Ye X, Meeker JD et al. Potential sources of bisphenol a in the neonatal intensive care unit. Pediatrics 2013; 131: 483–489.

    Article  Google Scholar 

  20. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL . Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 2005; 113: 391–395.

    Article  CAS  Google Scholar 

  21. Lakind JS, Naiman DQ . Daily intake of bisphenol A and potential sources of exposure: 2005-2006 National Health and Nutrition Examination Survey. Journal of Exposure Science and Environmental Epidemiology. 2011; 21: 272–279.

  22. CERHR. NTP-CERHR Expert Panel Report on the Reproductive and Developmental Toxicity of Bisphenol A.National Toxicology Program, U.S. Department of Health and Human Services: Research Triangle Park, NC 2007.

  23. Koch HM, Kolossa-Gehring M, Schroter-Kermani C, Angerer J, Bruning T . Bisphenol A in 24 h urine and plasma samples of the German Environmental Specimen Bank from 1995 to 2009: A retrospective exposure evaluation. J Expos Sci Environ Epidemiol 2012; 22: 610–616.

    Article  CAS  Google Scholar 

  24. Wolff MS, Teitelbaum SL, Windham G, Pinney SM, Britton JA, Chelimo C et al. Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls. Environ Health Perspect 2007; 115: 116–121.

    Article  CAS  Google Scholar 

  25. Lorber M, Calafat AM . Dose reconstruction of di-2-ethylhexyl phthalate using a simple pharmacokinetic model (accepted for publication). Environ Health Perspect 2012; 120: 1705–1710.

    Article  CAS  Google Scholar 

  26. NIH National Center for Biotechnology Information. PubChem BioAssay Database; CID=16212886, Source=Scripps Research Institute Molecular Screening Center http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=16212886 accessed on 3 December 2012.

  27. Lorber M, Angerer J, Koch HM . A simple pharmacokinetic model to characterize exposure of Americans to di-2-ethylhexyl phthalate. J Expos Sci Environ Epidemiol 2010; 20: 38–53.

    Article  CAS  Google Scholar 

  28. Crump KS, Gibbs JP . Benchmark calculations for perchlorate from three human cohorts. Environ Health Perspect 2005; 113: 1001–1008.

    Article  CAS  Google Scholar 

  29. Pottenger LH, Domoradzki JY, Markham DA, Hansen SC, Cagen SZ, Waechter JM, Jr . The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol Sci 2000; 54: 3–18.

    Article  CAS  Google Scholar 

  30. Preau JL, Wong LY, Silva MJ, Needham LL, Calafat AM . Variability over 1 week in the urinary concentrations of metabolites of diethyl phthalate and di(2-ethylhexyl) phthalate among eight adults: an observational study. Environ Health Perspect 2010; 118: 1748–1754.

    Article  CAS  Google Scholar 

  31. Ye XY, Wong LY, Bishop AM, Calafat AM . Variability of urinary concentrations of bisphenol a in spot samples, first morning voids, and 24-hour collections. Environ Health Perspect 2011; 119: 983–988.

    Article  CAS  Google Scholar 

  32. Li Z, Romanoff LC, Lewin MD, Porter EN, Trinidad DA, Needham LL et al. Variability of urinary concentrations of polycyclic aromatic hydrocarbon metabolite in general population and comparison of spot, first-morning, and 24-h void sampling. J Expos Sci Environ Epidemiol 2010; 20: 526–535.

    Article  CAS  Google Scholar 

  33. Ye X, Kuklenyik Z, Needham LL, Calafat AM . Quantification of urinary conjugates of bisphenol A, 2,5-dichlorophenol, and 2-hydroxy-4-methoxybenzophenone in humans by online solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2005; 383: 638–644.

    Article  CAS  Google Scholar 

  34. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV . Human exposure to bisphenol A (BPA). Reprod toxicol. 2007; 24: 139–177.

  35. Kang JH, Kondo F, Katayama Y . Human exposure to bisphenol A. Toxicology 2006; 226: 79–89.

    CAS  PubMed  Google Scholar 

  36. Verner MA, Magher T, Haddad S . High concentrations of commonly used drugs can inhibit the in vitro glucuronidation of bisphenol A and nonylphenol in rats. Xenobiotica 2010; 40: 83–92.

    Article  CAS  Google Scholar 

  37. Fisher JW, Twaddle NC, Vanlandingham M, Doerge DR . Pharmacokinetic modeling: Prediction and evaluation of route dependent dosimetry of bisphenol A in monkeys with extrapolation to humans. Toxicol Appl Pharmacol 2011; 257: 122–136.

    Article  CAS  Google Scholar 

  38. Shin BS, Hwang SW, Bulitta JB, Lee JB, Du Yang S, Park JS et al. Assessment of bisphenol a exposure in korean pregnant women by physiologically based pharmacokinetic modeling. J Toxicol Environ Health A 2010; 73: 1586–1598.

    Article  CAS  Google Scholar 

  39. Teeguarden JG, Waechter JM, Clewell HJ, Covington TR, Barton HA . Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: A physiologically based pharmacokinetic approach. Toxicol Sci 2005; 85: 823–838.

    Article  CAS  Google Scholar 

  40. Volkel W, Kiranoglu M, Fromme H . Determination of free and total bisphenol A in urine of infants. Environ Res 2011; 111: 143–148.

    Article  Google Scholar 

  41. Becker K, Goen T, Seiwert M, Conrad A, Pick-Fuss H, Muller J et al. GerES IV: phthalate metabolites and bisphenol A in urine of German children. Int J Hygiene Environ Health 2009; 212: 685–692.

    Article  CAS  Google Scholar 

  42. NTP NTP brief on bisphenol A [CAS No. 80-05-07]. In: NTP-CERHR monograph on the potential human reproductive and developmental effects of bisphenol A. United States Department of Health and Human Services, National Toxicology Program: Research Triangle Park, NC 2008.

Download references

Acknowledgements

We acknowledge Wolfgang Dekant, Wolfgang Voelkel, and Thomas Colnot for provision of data and helpful advice during manuscript development, and all study participants. We also thank Andreas Sjodin for designing the original study to assess the variability of urinary concentrations of polycylic aromatic hydrocarbons metabolites and for providing the samples that we used to analyze for BPA, and Pam Olive, Amber Bishop, and Jack Reidy for technical assistance in measuring the urinary concentrations of creatinine and BPA.

Disclaimer

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US Environmental Protection Agency or of the US Centers for Disease Control and Prevention.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Krista L Y Christensen.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Journal of Exposure Science and Environmental Epidemiology website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Christensen, K., Lorber, M., Ye, X. et al. Reconstruction of bisphenol A intake using a simple pharmacokinetic model. J Expo Sci Environ Epidemiol 25, 240–248 (2015). https://doi.org/10.1038/jes.2013.81

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jes.2013.81

Keywords

This article is cited by

Search

Quick links